They reported that treatment of atopic dermatitis mouse model with ZnO NPs suppresses local inflammation by down-regulation of the expression levels of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. This evidence concerns the gene TNF and atopic eczema.